{"groups":[{"description":"6 once-weekly intravesical instillations of UGN-102 (75 mg mitomycin).","id":"FG000","title":"UGN-102"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"171"}],"type":"Ongoing in the Study"},{"reasons":[{"groupId":"FG000","numSubjects":"10"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"7"}],"type":"Lost to Follow-up"},{"reasons":[{"groupId":"FG000","numSubjects":"3"}],"type":"Adverse Event"},{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"Noncompliance"},{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"Physician Decision"},{"reasons":[{"groupId":"FG000","numSubjects":"4"}],"type":"Other Reason"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"240"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"43"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"197"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}